Abstract 2497: Extracellular vesicle-mediated reversal of the prostate cancer phenotype
| Autor: | Joseph F. Renzulli, Kiriaki Panagopoulos, Devasis Chatterjee, Sam Cross-Knorr, Peter J. Quesenberry |
|---|---|
| Rok vydání: | 2014 |
| Předmět: | |
| Zdroj: | Cancer Research. 74:2497-2497 |
| ISSN: | 1538-7445 0008-5472 |
| Popis: | Extracellular vesicle (EV) trafficking is a fundamental cellular process that occurs in cells and is required for different aspects of pathophysiology. EV trafficking leads to changes in cellular function including apoptosis, angiogenesis and proliferation required for increased tumor formation. In our current study we report several phenotypic changes mediated by EVs isolated from non-malignant and malignant prostate cells as well as patient biopsied prostate tumor samples. EVs can reverse the resistance of prostate cancer cells to camptothecin EVs isolated from non-malignant PrECs (Prostate Epithelial Cells) can reverse soft agar colony formation of malignant DU145 cells, with the reciprocal effect observed. Isolation of EVs from 2 Gleason grade 8 prostate cancer patients significantly induced soft agar colony formation of non-malignant PrECs. We have identified proteins via antibody and Mass spectrometry analysis that may be responsible for the phenotypic changes. Mass spectrometry analysis of protein lysates using ProteoIQ revealed protein candidates associated with gene ontology annotations that may be responsible for this phenotypic change. Ingenuity Pathway Analysis was used to identify statistically relevant canonical pathways and functions associated the protein IDs and expression values obtained using ProteoIQ. Western blot analysis confirmed the increase of 14-3-3 zeta, pRKIP and prohibitin protein levels in PrEC cells co-cultured with patient EVs. 14-3-3 proteins were also found as common proteins of 3 other Gleason grade 8 patients. Our results provides a rational basis to further investigate putative proteins, such as 14-3-3 and prohibitin and genetic factors that may be responsible for phenotypic changes that are associated with prostate cancer progression. Citation Format: Kiriaki Panagopoulos, Sam Cross-Knorr, Joseph F. Renzulli, Peter J. Quesenberry, Devasis Chatterjee. Extracellular vesicle-mediated reversal of the prostate cancer phenotype. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 2497. doi:10.1158/1538-7445.AM2014-2497 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|